Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
 
Letter

The future of mammary stem cell biology: the power of in vivo transplants – authors' response

Gilbert H Smith1 email and Daniel Medina2

1Mammary Stem Cell Biology Section, Mammary Biology and Tumorigenesis Laboratory, CCR, NCI, Convent Drive, National Institutes of Health, Bethesda, Maryland 20892, USA

2Department of Molecular and Cellular Biology, Baylor College of Medicine, Baylor Plaza, Houston, Texas 77030, USA

author email corresponding author email

Breast Cancer Research 2008, 10:403doi:10.1186/bcr1993



See related letter by Lindeman et al., http://breast-cancer-research.com/content/10/3/402 and related review article by Smith and Medina, http://breast-cancer-research.com/content/10/1/203

The electronic version of this article is the complete one and can be found online at: http://breast-cancer-research.com/content/10/3/403

Published: 29 May 2008

© 2008 BioMed Central Ltd

Letter

The letter from Lindeman and coworkers [1] conveys their concern regarding the future of prospective isolation and characterization of individual cells that may be characterized as mammary stem cells upon in vivo transplantation. As they have pointed out, the difficulties encountered in identifying specific mammary epithelial subtypes by different levels of fluorescence (particularly for membrane components that decorate most if not all mammary epithelial cells) leads to differential reporting and 'resultant confusion' and 'underscores the need for improved standardization'.

Our 're-evaluation' [2] sought to highlight these concerns for those mammary and nonmammary biologists, who have been regaled in the current literature with glowing claims of the prospective isolation of normal and 'cancer stem cells'. Despite tremendous efforts to isolate stem and progenitor subpopulations from mammary glands using surface markers, the following critical questions remain; where is the stem cell located?; what constitutes a niche environment?; and what critical molecular mechanisms regulate these interactions? Our understanding of mammary 'stem cell' and 'progenitors' will be greatly enhanced when these questions are answered. In vivo lineage-tracing experiments will be critical in resolving these issues. The mouse mammary fat pad represents a powerful and under-utilized site for the rigorous delineation of the complex interaction between mammary epithelial cells (of all subtypes), their stromal counterparts and extrinsic signals, which are indispensable to mammary gland growth, development, and differentiation. It was recently demonstrated that admixtures of mammary epithelial cells and cells from adult male seminiferous tubules produce chimeric glands, in which both testicular and mammary cell progeny play interchangeable roles in mammary growth, development, and differentiation [3]. This experimental model holds great promise for the subsequent identification of the cellular, stromal and extrinsic signals necessary to specify, initiate, generate, and maintain a fully functional mammary gland population, and has been extended to include cells from other adult organs.

Competing interests

The authors declare that they have no competing interests.

References

  1. Lindeman GJ, Visvader JE, Smalley MJ, Eaves CJ: The future of mammary stem cell biology: the power of in vivo transplants.

    Breast Cancer Res 2008, 10:402. OpenURL

  2. Smith GH, Medina D: Re-evaluation of mammary stem cell biology based on in vivo transplantation.

    Breast Cancer Res 2008, 10:203. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL

  3. Boulanger CA, Mack DL, Booth BW, Smith GH: Interaction with the mammary microenvironment redirects spermatogenic cell fate in vivo.

    Proc Natl Acad Sci USA 2007, 104:3871-3876. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

Have something to say? Post a comment on this article!


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.